Hair Exosomes in the UK: Evidence, Safety and Suitability

Exosomes are tiny particles released by cells that can carry signals. A service described as “hair exosomes” may use a different preparation or method from one described in a research paper. A positive result in one small study cannot establish that every product sold under this name will regrow hair.

How strong is the evidence?

Early human studies have examined changes such as hair density in selected people with pattern hair loss. Product source, preparation, delivery and follow-up differ. A photograph showing thicker-looking hair does not tell you how much change came from the product, from accompanying treatment or from differences in styling and light.

What should you ask a UK provider?

Ask for the exact product name, manufacturer, intended use and proposed route of administration. Request an explanation of how that use is supported in the UK and whether published evidence relates to that same preparation and route. The MHRA’s classification guidance explains why claims and intended use matter. A product description alone does not establish its regulatory status.

Who should have their hair loss assessed first?

A new bald patch or painful, inflamed scalp needs medical assessment. For gradual thinning, ask what diagnosis is being treated, which established alternatives are available and how they compare. A useful written plan names the product, records other treatments and agrees how progress and adverse effects will be reviewed.